New research to speed TB drugs to those who need it most New York and Bangalore, India, May 3, 2010 The TB Alliance and AstraZeneca announced today at the 2010 BIO International Convention that they have entered into a research collaboration agreement to accelerate the discovery, development and...
News about 'tb alliance'
25 Apr 2010
Open Forum 4: Key Issues in TB Drug Development August 18-19, 2010 | Addis Ababa, Ethiopia REGISTER NOW FOR: Open Forum 4: Key Issues in TB Drug Development August 18-19, 2010 | Addis Ababa, Ethiopia International Conference to address regulatory challenges to TB drug development in Africa. Don’t...
24 Mar 2010
CPTR could deliver a new TB regimen in just 6 years as opposed to 24 After a decades-long drought, new pharmaceutical discoveries and repurposing of existing antimicrobials have produced about 10 drugs from 7 different classes which are now in various stages of clinical development for TB. Many...
17 Mar 2010
Today marks the launch of an exciting new initiative in TB R&D. The US Food and Drug Administration (FDA) has supported the Critical Path to TB Drug Regimens (CPTR). The CPTR comprises a broad collaborative network of partners including pharmaceutical companies, government, academia, and...
24 Feb 2010
Aren't These Lives Worth Saving, Too? This is a guest blog jointly submitted by Jerald C. Sadoff, MD, the President & Chief Executive Officer of the Aeras Global TB Vaccine Foundation and Mel Spigelman, MD, the President & Chief Executive Officer of the Global Alliance for TB Drug...